Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Is measurement of nuchal translucency thickness a useful screening tool for heart defects? A study of 16 383 fetuses

19 May 2006

Abstract excerpt

OBJECTIVE: To determine the performance of nuchal translucency thickness (NT) measurement as a screening method for congenital heart defects (CHD) among fetuses with normal karyotype. METHODS: An NT measurement was made in 16 383 consecutive euploid fetuses derived from an unselected pregnant population. The cut-offs for increased risk of heart defects, chosen a priori and tested prospectively, were: NT >or= 95th...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Assisted Reproductive Technology and Twin Pregnancy
Share to Congenital Heart Disease Studies
Share to Prenatal Screening and Diagnostics

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 16715530
DOI: 10.1002/uog.2792

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Is measurement of nuchal translucency thickness a useful screening tool for heart defects? A study of 16 383 fetusesPMID 16715530Read ↗

Nuchal translucency and major congenital heart defects in fetuses with normal karyotype: a meta‐analysisSemantic proximity Read ↗

Increased nuchal translucency in children with congenital heart defects and normal karyotype—is there a correlation with mortality?Semantic proximity Read ↗

Prevalence of increased nuchal translucency in fetuses with congenital cardiac disease and a normal karyotypeSemantic proximity Read ↗

Prenatal detection of congenital heart disease in a low risk population undergoing first and second trimester screeningSemantic proximity Read ↗

Pregnancy outcome for fetuses with increased nuchal translucency but normal karyotypeSemantic proximity Read ↗

Fetal nuchal translucency: ultrasound screening for chromosomal defects in first trimester of pregnancy.Semantic proximity Read ↗

Cut‐off value of nuchal translucency as indication for chromosomal microarray analysisSemantic proximity Read ↗

‘Normal’ nuchal translucency: a justification to refrain from detailed scan? Analysis of 6858 cases with special reference to ethical aspectsSemantic proximity Read ↗

Increased nuchal translucency in euploid fetuses—what should we be telling the parents?Semantic proximity Read ↗

Prenatal diagnosis of congenital heart diseaseSemantic proximity Read ↗

Clinical aspects of prenatally detected congenital heart malformations and the yield of chromosomal microarray analysisSemantic proximity Read ↗

Elevated nuchal translucency, is it time to discuss the cut off?. A retrospective studySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.